Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders. Autobahn Therapeutics is backed by investors that include ARCH Venture Partners, Bristol-Myers Squibb, Cowen Healthcare Investments, Invus, and Samsara BioCapital and is headquartered in San Diego.